Lecture «Recent advances in fragment-based drug discovery»

Lecture «Recent advances in fragment-based drug discovery»

The event passed
11 Nov 2019
Moscow, Ordzhonikidze st., 3, room 208
About the event

Fragment-based drug design (FBDD) can be considered as the most successful structure-based drug design (SBDD) approach. It includes: (i) identification of low molecular weight fragments as hits, followed by (ii) determination of their binding mode using biophysical methods, such as X-ray crystallography or NMR spectroscopy, just to name a few, and then by (iii) optimization, through evolving or combining (linking) fragments. X-ray protein crystallography is one of the most sensitive biophysical methods used for screening, as it provides detailed structural information of the protein-fragment complexes at the atomic level.

FBDD has evolved significantly over the past 20 years and is now recognized as a good alternative to traditional methods of hit identification and high-throughput screening (HTS). The usefulness in drug discovery of fragment-based approaches is documented by over 30 clinical drug candidates and importantly a few FDA-approved drugs in oncology. The progresses in FBDD approaches are illustrated in this lecture along with success stories of FBDD in drug discovery.

The event starts at 12: 00

Related eventsAll events
17 Jun
Seminar “Mechano-sensitive blood proteins and their role in cellular hemostasis”
24 Jun
Seminar “Effects and challenges of wireless sensor networks and internet of things in smart cities”
18 Jun
Seminar “6TiSCH Tri-Layer Network Architecture for Energy-Efficient Offloading in Smart Industries”
8 Jun
Scientific seminar “Modeling of a propagation of fractions loaded with viscous fluid pressure”